Lion Biotechnologies

Lion Biotechnologies

Lion Biotechnologies

We are a publicly traded #biotech company focused on the development of novel #cancer #immunotherapy products for #melanoma and other solid tumors.
Founded
2013
Raised
$100M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$100,000,000
Post-IPO equity - 2016
Frazier Healthcare Partners OrbiMed Advisors Broadfin Capital +1
Team Size
1–10
Employees
The Motley Fool

Why Lion Biotechnologies Inc. Stock Is Roaring Higher Today

$100,000,000 Post-IPO equity
PE Hub

Lion Biotechnologies racks up $100 mln, also hires new president/CEO